Journals / İstanbul Tıp Dergisi / 2009 / Cilt: 10 - Sayı: 1

Type 2 Gastric Neuroendocrine Tumor Associated With Pernicious Anemia: Case Report

Pernisiyöz Anemi ile Birlikte Görülen Tip-2 Gastrik Nöroendokin Tümör: Olgu Sunumu

Pages
47–50
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For better management patients gastric NE type 2 with MEN-1 life-long follow-up must be carefully done.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastric neuroendocrine tumours (NET) are rare.
📊
Key Findings & Data:Clinically they are classified in tumours type 1 to 4.
💡
Conclusion & Impact:For better management patients gastric NE type 2 with MEN-1 life-long follow-up must be carefully done.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gastric neuroendocrine tumours (NET) are rare. Clinically they are classified in tumours type 1 to 4. Type 2 tumors rarely seen, show intermediate malignant potential, and occur in patients with multiple endocrine neoplasia I (MEN I) and Zollinger Ellison syndrome.We represent, the patient 52 years old male with pernicious anemia who underwent upper gastrointestinal endoscopy were found to have multiple polypoid lesions located in the corpus and fundus of the stomach. Total gastrectomy with D-II lymphadenectomy was done for gastrik NET in general surgery department.In the case of pernisios anemia upper gastrointestinal endoscopy must be planned and gastrik neuroendocrine tumours must be in differantial diagnosis. For better management patients gastric NE type 2 with MEN-1 life-long follow-up must be carefully done.

Özet

Gastrik nöroendokrin tümörler (NET) nadiren görülürler ve klinik olarak 4 sınıfa incelenirler. Tip 2 nadir görülür fazla maling potansiyel taşımaz. Sıklıkla multiple endokrin neoplazi (MEN-1) ve Zollinger Ellison sendromu ile birlikte görülürler. Sunduğumuz olgu; Pernisiyöz anemi tanısı alan ve ayırıcı tanı için yapılan gastroskopi mide korpus ve fundusta multiplepolipoid lezyonları olan 52 yaşında erkek hastadır. Mideden alınan patoloji sonucu gastrik NET rapor edilmiş ve genel cerrahi kliniğinde total gastrektomi D2 lenf nodu disseksiyonu yapılmıştır. Pernisyöz anemi varlığı mutlaka üst gastrointestinal endoskopi planlanmalı ve ayırıcı tanıda gasrik nöroendokrin tümörler de göz önünde bulundurulmalıdır. Bu hastaların takipleri titizlikle yapılmalıdır.

🔖

Cite This Article

ARIKAN, S., TULUK, G., ERSÖZ, F., ÖZCAN, Ö., BEKTAŞ, H. (2022). Type 2 Gastric Neuroendocrine Tumor Associated With Pernicious Anemia: Case Report. İstanbul Tıp Dergisi, Cilt: 10 - Sayı: 1, 47–50. https://ajindex.com/articles/552625

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Klöppel G, Heitz PU. Die disseminierten (diffusen) endokrinen Zellen. In Spezielle pathologische Anatomie, Bd 14. W. Doerr & G. Seifert, Springer. Berlin. Eds. 1981
  2. Solcia E, Klöppel G, Sobin LH, et al. Histological typing of endocrine tumours. 2nd Ed. WHO International Histological Classification of Tumours. Springer. Berlin. 2000. 3.Soga J. Gastric carcinoids: a statistical evaluation of 1,094 cases collected from the literature. Surg Today. 1997
  3. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol. 2004
  4. Hakanson R, Owman C. Concomitant histochemical demonstration of histamine and catecholamines in enterochromaffin-like cells of gastric mucosa. Life Sci. 1967
  5. Solcia E, Rindi G, Silini E, et al. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. Baillieres Clin Gastroenterol. 1993
  6. Hakanson R, Chen D, Andersson K, et al. The biology and physiology of the ECL cell. Yale J Biol Med. 1994
  7. Bordi C, D'Adda T, Azzoni C, et al. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995
  8. 19(suppl 1): 8 -19. 9.Andersson K, Chen D, Mattsson H, et al. Physiological significance of ECL cell histamine. Yale J Biol Med. 1998
  9. Prinz C, Zanner R, Gerhard M, et al. The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol. 1999
  10. 11Bakke I, Qvigstad G, Sandvik AK, et al. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand J Gastroenterol. 2001
  11. Klöppel G, Clemens A. The biological relevance of gastric neuroendocrine tumors. Yale J. Biol. Med. 1996
  12. Bordi C, Yu JY, Baggi MT, et al. Gastric carcinoids and their precursor lesions: a histologic and immunohistochemical study of 23 cases. Cancer. 1991
  13. Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a cli-nicopathologic study. Gastroenterology. 1993
  14. Ahlman H, Kolby L, Lundell L, et al. Clinical management of gastric carcinoid tumors. Digestion 1994
  15. 55(suppl 3): 77-85. 16.Gilligan CJ, Lawton GP, Tang LH, et al. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol. 1995
  16. 338 352. 17.Borch K. Atrophic gastrit